B. Pignon

1.4k total citations
44 papers, 832 citations indexed

About

B. Pignon is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, B. Pignon has authored 44 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Genetics and 11 papers in Oncology. Recurrent topics in B. Pignon's work include Acute Myeloid Leukemia Research (9 papers), Blood properties and coagulation (7 papers) and Multiple Myeloma Research and Treatments (7 papers). B. Pignon is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Blood properties and coagulation (7 papers) and Multiple Myeloma Research and Treatments (7 papers). B. Pignon collaborates with scholars based in France, United States and Canada. B. Pignon's co-authors include B Desablens, Denis Guyotat, Jean‐Luc Harousseau, Denis Caillot, B. Audhuy, Philippe Casassus, Francis Witz, Jean‐Yves Cahn, Thierry Lamy and Nöel Milpied and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

B. Pignon

43 papers receiving 807 citations

Peers

B. Pignon

HEMAT

ONCOL

PFM

GENET

Jean Pierre Jouet France

Pascual Fernández Spain

Tung‐Liang Lin Taiwan

Razelle Kurzrock United States

Anand P. Jillella United States

Anne Marie Stoppa France

Kang Howson‐Jan Canada

Paola Masolini Italy

Potito Rosario Scalzulli Italy

G. Nedellec France

Jean Pierre Jouet France

B. Pignon

731 ×1.7

HEMAT

164 ×0.6

ONCOL

162 ×0.8

138 ×0.7

PFM

356 ×1.9

GENET

Citations per year, relative to B. Pignon B. Pignon (= 1×) peers Jean Pierre Jouet

Countries citing papers authored by B. Pignon

Since Specialization

Citations

This map shows the geographic impact of B. Pignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Pignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Pignon more than expected).

Fields of papers citing papers by B. Pignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Pignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Pignon. The network helps show where B. Pignon may publish in the future.

Co-authorship network of co-authors of B. Pignon

This figure shows the co-authorship network connecting the top 25 collaborators of B. Pignon. A scholar is included among the top collaborators of B. Pignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Pignon. B. Pignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Raphael M., Camille Boulagnon‐Rombi, Marie-Danièle Diébold, et al.. (2016). Portal hypertension with extensive fibrosis and plasma cell infiltration in multiple myeloma. Clinics and Research in Hepatology and Gastroenterology. 40(6). e71–e73. 2 indexed citations

Tournois, Claire, et al.. (2016). Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products. Cytotherapy. 19(2). 299–310. 12 indexed citations

Tournois, Claire, Fabien Vitry, Marie‐Antoinette Sevestre, et al.. (2008). Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product. Vox Sanguinis. 96(3). 256–265. 28 indexed citations

Eschard, Jean‐Paul, et al.. (2005). Factors useful for predicting survival of myeloma patients in everyday practice. A 10-year study of 148 patients older than 55 years. Joint Bone Spine. 72(6). 544–549. 4 indexed citations

Deconinck, Éric, Mathilde Hunault, Nöel Milpied, et al.. (2005). Intensive Therapy before or during the Conditioning Regimen of Allogeneic Marrow Transplantation in Adult Acute Lymphoblastic Leukemia Patients: We Must Choose to Reduce Toxicity—A Groupe Ouest-Est d’Etude des Leucémies et Autres Maladies du Sang Study. Biology of Blood and Marrow Transplantation. 11(6). 448–454. 4 indexed citations

Foussard, C., Philippe Colombat, Hervé Maisonneuve, et al.. (2005). Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies. Annals of Oncology. 16(3). 466–472. 14 indexed citations

Eschard, Jean‐Paul, et al.. (2005). Facteurs pronostiques du myélome utilisables en pratique courante : suivi sur dix ans de 148 malades âgés de plus de 55 ans. Revue du Rhumatisme. 72(12). 1299–1305. 3 indexed citations

Tournilhac, Olivier, V. Leblond, Reza Tabrizi, et al.. (2003). Transplantation in Waldenstrom's macroglobulinemia—the French experience. Seminars in Oncology. 30(2). 291–296. 38 indexed citations

Léone, J., et al.. (1998). Effect of chlorambucil on bone mineral density in the course of chronic lymphoid leukemia. European Journal Of Haematology. 61(2). 135–139. 4 indexed citations

10.

Solal‐Céligny, Philippe, Éric Lepage, Nicole Brousse, et al.. (1998). Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.. Journal of Clinical Oncology. 16(7). 2332–2338. 150 indexed citations

11.

Harousseau, Jean‐Luc, Régis Bataille, Michel Attal, et al.. (1996). Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the french registry on autologous transplantation in multiple myeloma. Stem Cells. 13(S2). 132–139. 35 indexed citations

12.

Aubert, Dominique, et al.. (1996). Characterization of specific anti‐Candida IgM, IgA and IgE: diagnostic value in deep‐seated infections. Mycoses. 39(5-6). 169–176. 5 indexed citations

13.

Léone, J., Jean‐Pierre Vilque, B. Pignon, et al.. (1996). Avascular necrosis of the femoral head as a complication of chronic myelogenous leukaemia. Skeletal Radiology. 25(7). 696–698. 12 indexed citations

14.

Thiéfin, Gérard, et al.. (1995). [Lymphocytic ascites revealing systemic mastocytosis].. PubMed. 19(11). 948–51. 2 indexed citations

15.

Salmon-Ehr, V, et al.. (1995). Dermatose neutrophilique aiguë fébrile pustuleuse et bulleuse (syndrome de Sweet) révélant une leucémie aiguë myéloblastique. La Revue de Médecine Interne. 16(5). 347–350. 4 indexed citations

16.

Morjani, Hamid, B. Pignon, Jean‐Marc Millot, et al.. (1992). Intranuclear concentration measurements of doxorubicin in living leucocytes from patients treated for a lympho-proliferative disorder. Leukemia Research. 16(6-7). 647–653. 6 indexed citations

17.

Eschard, J.P. & B. Pignon. (1992). Facteurs pronostiques et surveillance du myélome. La Revue de Médecine Interne. 13(4). 273–277. 2 indexed citations

18.

Pignon, B., et al.. (1990). Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients.. PubMed. 32(4). 249–52. 5 indexed citations

19.

Pignon, B., S. Müller, Damien Jolly, et al.. (1989). Validation of a method for erythrocyte aggregation measurement using light back-scattering. Clinical Hemorheology and Microcirculation. 9(5). 739–749. 1 indexed citations

20.

Hervé, P, et al.. (1982). Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remission.. PubMed. 66(11). 1983–5. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact